No profile data available.
10x Genomics, Inc. (TXG) is a healthcare company in the biological analysis equipment industry, based in Pleasanton, United States, with about 1,306 full-time employees.
It reported revenue of $642.82 million for fiscal year 2025, up 5.2% from fiscal year 2024, and net income of -$43.54 million. United States was its largest region in fiscal year 2025, with 54% of revenue. Its market capitalization was $2.30 billion as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.
10x Genomics reported $642.82 million in revenue for fiscal year 2025, up 5.2% from $610.79 million in fiscal year 2024.
United States: 54% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (25%).
$2.30 billion as of December 4, 2025.
Listed companies of a similar size in the same industry (biological analysis equipment) include Bio-Techne Corporation (TECH), Bruker Corporation (BRKR), Neogen Corporation (NEOG), BioLife Solutions, Inc. (BLFS).